Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 15, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 000-21617    
Entity Registrant Name ProPhase Labs, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 23-2577138    
Entity Address, Address Line One 711 Stewart Avenue    
Entity Address, Address Line Two Suite 200    
Entity Address, City or Town Garden City    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 11530    
City Area Code (215)    
Local Phone Number 345-0919    
Title of 12(b) Security Common Stock, $0.0005 par value per share    
Trading Symbol PRPH    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 100,240,301
Entity Common Stock, Shares Outstanding   18,045,209  
Documents Incorporated by Reference Portions of the Registrant’s definitive proxy statement relating to its 2024 annual meeting of stockholders (the “2024 Proxy Statement”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2024 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates    
Entity Central Index Key 0000868278    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false